Mitsubishi UFJ Trust & Banking Corp
Position in DNLI — Denali Therapeutics Inc.
CIK 1462160
TOKYO, M0
Position in DNLI
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$218,465
-$5,064,772 QoQ
Shares Held
8,494
-96.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#192
of 290 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Trust & Banking Corp holds $324,055,173 across 66 Biotechnology names. DNLI ranks #44 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
174,812 | $86,834,364 | |
| 2 | RPRX |
Royalty Pharma plc
|
1,307,514 | $73,312,309 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,523 | $40,856,211 | |
| 4 | INCY |
Incyte Corp
|
312,130 | $35,383,056 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
93,646 | $28,190,254 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
65,240 | $12,218,147 | |
| 7 | INSM |
INSMED Inc
|
91,077 | $9,710,629 | |
| 8 | EXEL |
Exelixis, Inc.
|
170,171 | $9,259,004 |
All Filings in DNLI
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $218,465 | 8,494 | Shares | Defined | 2026-08-06 | |
| 2023-12-31 | $5,283,237 | 246,190 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,002,504 | 290,960 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $8,545,505 | 289,580 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $7,018,675 | 304,630 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $8,395,004 | 301,870 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $9,435,947 | 307,460 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $9,267,212 | 314,890 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $10,130,011 | 314,890 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $13,783,184 | 309,040 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $17,088,928 | 338,730 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $27,085,332 | 345,300 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $20,946,564 | 366,840 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $31,027,216 | 370,430 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $14,228,451 | 397,110 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $10,105,063 | 417,910 | Shares | Sole | 2020-09-11 | |
| 2020-03-31 | $7,428,967 | 424,270 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||